Related references
Note: Only part of the references are listed.BCL-2 and PAX2 Expressions in EIN which Had Been Previously Diagnosed as Non-Atypical Hyperplasia
Levent Trabzonlu et al.
PATHOLOGY & ONCOLOGY RESEARCH (2019)
Hysteroscopic Endometrial Focal Resection followed by Levonorgestrel Intrauterine Device Insertion as a Fertility-Sparing Treatment of Atypical Endometrial Hyperplasia and Early Endometrial Cancer: A Retrospective Study
Pierluigi Giampaolino et al.
JOURNAL OF MINIMALLY INVASIVE GYNECOLOGY (2019)
Endometrial hyperplasia and the risk of coexistent cancer: WHO versus EIN criteria
Antonio Travaglino et al.
HISTOPATHOLOGY (2019)
Loss of B-cell lymphoma 2 immunohistochemical expression in endometrial hyperplasia: A specific marker of precancer and novel indication for treatment A systematic review and meta-analysis
Antonio Travaglino et al.
ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA (2018)
UnPAXing the Divergent Roles of PAX2 and PAX8 in High-Grade Serous Ovarian Cancer
Laura R. Hardy et al.
CANCERS (2018)
PTEN as a predictive marker of response to conservative treatment in endometrial hyperplasia and early endometrial cancer. A systematic review and meta-analysis
Antonio Travaglino et al.
EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY (2018)
PAX2 function, regulation and targeting in fallopiantube-derived high-grade serous ovarian cancer
D. A. Modi et al.
ONCOGENE (2017)
PAX2 maintains the differentiation of mouse oviductal epithelium and inhibits the transition to a stem cell-like state
Kholoud Alwosaibai et al.
ONCOTARGET (2017)
Synthesizing Evidence from Diagnostic Accuracy TEsts: the SEDATE guideline
A. Sotiriadis et al.
ULTRASOUND IN OBSTETRICS & GYNECOLOGY (2016)
Divergent Roles of PAX2 in the Etiology and Progression of Ovarian Cancer
Ensaf M. Al-Hujaily et al.
CANCER PREVENTION RESEARCH (2015)
Pax2 Expression in Simultaneously Diagnosed WHO and EIN Classification Systems
Amy K. Joiner et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY (2015)
Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement
David Moher et al.
SYSTEMATIC REVIEWS (2015)
Utility of PAX2 as a Marker for Diagnosis of Endometrial Intraepithelial Neoplasia
Charles M. Quick et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2012)
Biomarkers of progestin therapy resistance and endometrial hyperplasia progression
Kristen Upson et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2012)
Expression pattern of PAX2 in hyperplastic and malignant endometrium
Korhan Kahraman et al.
ARCHIVES OF GYNECOLOGY AND OBSTETRICS (2012)
PAX2 Loss by Immunohistochemistry Occurs Early and Often in Endometrial Hyperplasia
Kimberly H. Allison et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY (2012)
QUADAS-2: A Revised Tool for the Quality Assessment of Diagnostic Accuracy Studies
Penny F. Whiting et al.
ANNALS OF INTERNAL MEDICINE (2011)
RNA interference of pax2 inhibits growth of transplanted human endometrial cancer cells in nude mice
Li-Ping Zhang et al.
Chinese Journal of Cancer (2011)
PAX2 Distinguishes Benign Mesonephric and Mullerian Glandular Lesions of the Cervix From Endocervical Adenocarcinoma, Including Minimal Deviation Adenocarcinoma
Joseph T. Rabban et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2010)
Joint Loss of PAX2 and PTEN Expression in Endometrial Precancers and Cancer
Nicolas M. Monte et al.
CANCER RESEARCH (2010)
Early aberrant insulin-like growth factor signaling in the progression to endometrial carcinoma is augmented by tamoxifen
Pamela L. Strissel et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
PAX genes: Roles in development, pathophysiology, and cancer
Deborah Lang et al.
BIOCHEMICAL PHARMACOLOGY (2007)
My approach to the interpretation of endometrial biopsies and curettings
W. G. McCluggage
JOURNAL OF CLINICAL PATHOLOGY (2006)
Molecular mechanisms of oestrogen and SERMs in endometrial carcinogenesis
YF Shang
NATURE REVIEWS CANCER (2006)
A PANorama of PAX genes in cancer and development
EJD Robson et al.
NATURE REVIEWS CANCER (2006)
Hypomethylation-linked activation of PAX2 mediates tamoxifen-stimulated endometrial carcinogenesis
HJ Wu et al.
NATURE (2005)
Paired-box genes are frequently expressed in cancer and often required for cancer cell survival
A Muratovska et al.
ONCOGENE (2003)
Share Paper
